Versorgungsrealität der molekularen Diagnostik maligner Erkrankungen
Authors:
- 22 August 2017
- journal article
- research article
- Published by Springer Nature in Der Onkologe
- Vol. 23 (11) , 900-910
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- A Genomics-Based Classification of Human Lung TumorsScience Translational Medicine, 2013
- Crizotinib versus Chemotherapy in AdvancedALK-Positive Lung CancerNew England Journal of Medicine, 2013
- Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trialThe Lancet Oncology, 2012
- Pertuzumab plus Trastuzumab plus Docetaxel for Metastatic Breast CancerNew England Journal of Medicine, 2012
- Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trialThe Lancet, 2010
- Gefitinib or Chemotherapy for Non–Small-Cell Lung Cancer with Mutated EGFRNew England Journal of Medicine, 2010
- A comprehensive catalogue of somatic mutations from a human cancer genomeNature, 2009
- Lapatinib Combined With Letrozole Versus Letrozole and Placebo As First-Line Therapy for Postmenopausal Hormone Receptor–Positive Metastatic Breast CancerJournal of Clinical Oncology, 2009
- Kinase Mutations and Imatinib Response in Patients With Metastatic Gastrointestinal Stromal TumorJournal of Clinical Oncology, 2003
- Addiction to Oncogenes--the Achilles Heal of CancerScience, 2002